Amino Acid Asp181 of 5′-Flap Endonuclease 1 Is a Useful Target for Chemotherapeutic Development
- 22 September 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 48 (42), 9952-9958
- https://doi.org/10.1021/bi9010754
Abstract
DNA alkylation-induced damage is one of the most efficacious anticancer therapeutic strategies. Enhanced DNA alkylation and weakened DNA repair capacity in cancer cells are responsible for the effectiveness of DNA-alkylating therapies. 5′-Flap endonuclease 1 (Fen1) is an important enzyme involved in base excision repair (BER), specifically in long-patch BER (LP-BER). Using the site-directed mutagenesis approach, we have identified an important role for amino acid Asp181 of Fen1 in its endonuclease activity. Asp181 is thought to be involved in Mg2+ binding in the active site. Using structure-based molecular docking of Fen1 targeted to its metal binding pocket M2 (Mg2+ site), we have identified a potent low-molecular weight inhibitor (LMI, NSC-281680) that efficiently blocks LP-BER. In this study, we have demonstrated that the interaction of this LMI with Fen1 blocked its endonuclease activity, thereby blocking LP-BER and enhancing the cytotoxic effect of DNA-alkylating agent Temozolomide (TMZ) in mismatch repair (MMR)-deficient and MMR-proficient colon cancer cells. The results further suggest that blockade of LP-BER by NSC-281680 may bypass other drug resistance mechanisms such as mismatch repair (MMR) defects. Therefore, our findings provide groundwork for the development of highly specific and safer structure-based small molecular inhibitors targeting the BER pathway, which can be used along with existing chemotherapeutic agents, like TMZ, as combination therapy for the treatment of colorectal cancer.Keywords
This publication has 58 references indexed in Scilit:
- Isolation and Characterization of Potentially Pathogenic Antimicrobial-Resistant Escherichia coli Strains from Chicken and Pig Farms in SpainApplied and Environmental Microbiology, 2010
- Spread of bla CTX-M-14 Is Driven Mainly by IncK Plasmids Disseminated among Escherichia coli Phylogroups A, B1, and D in SpainAntimicrobial Agents and Chemotherapy, 2009
- Spreading antibiotic resistance through spread manure: characteristics of a novel plasmid type with low %G+C contentEnvironmental Microbiology, 2009
- Prevalence of Sulfonamide Resistance Genes in Bacterial Isolates from Manured Agricultural Soils and Pig Slurry in the United KingdomAntimicrobial Agents and Chemotherapy, 2009
- Preservation of Integron Types among Enterobacteriaceae Producing Extended-Spectrum β-Lactamases in a Spanish Hospital over a 15-Year Period (1988 to 2003)Antimicrobial Agents and Chemotherapy, 2007
- Hypersensitivity phenotypes associated with genetic and synthetic inhibitor-induced base excision repair deficiencyDNA Repair, 2007
- Mechanism of Adenomatous Polyposis Coli (APC)-Mediated Blockage of Long-Patch Base Excision RepairBiochemistry, 2006
- Dissemination and Persistence of bla CTX-M-9 Are Linked to Class 1 Integrons Containing CR1 Associated with Defective Transposon Derivatives from Tn 402 Located in Early Antibiotic Resistance Plasmids of IncHI2, IncP1-α, and IncFI GroupsAntimicrobial Agents and Chemotherapy, 2006
- Temozolomide in the treatment of solid tumours: current results and rationale for dosing/schedulingCritical Reviews in Oncology/Hematology, 2005
- Targeted cancer therapyNature, 2004